Low levels of type II collagen formation (PRO-C2) are associated with response to sprifermin: a pre-defined, exploratory biomarker analysis from the FORWARD study
Anne‐Christine Bay‐Jensen, Angela A. Manginelli, M.A. Karsdal, Yunyun Luo, yuanjia he, M. Michaelis, Hans Guehring, C. Ladel
Topics & Concepts
PlaceboCartilageOsteoarthritisMedicineBiomarkerInternal medicineAnabolismType II collagenUrologyGastroenterologyPathologyChemistryAnatomyAlternative medicineBiochemistryOsteoarthritis Treatment and MechanismsFibroblast Growth Factor ResearchConnective Tissue Growth Factor Research